Frequency: Biomonthly
Time to first decision: 3 Weeks
Submission to publication: 8 Weeks
Acceptance rate: 39%
E-ISSN: 3005-480X
Frequency: Biomonthly
Time to first decision: 3 Weeks
Submission to publication: 8 Weeks
Acceptance rate: 39%
E-ISSN: 3005-480X
For studies involving human participants, authors must:
Identify the approving ethics committee or institutional review board (IRB) in the Materials and Methods section, including the committee’s name and approval identifiers (e.g., reference numbers).
Provide proof of ethics approval (or written approval from the committee if identifiers are not available) as a confidential supplementary file upon submission.
Include a statement confirming that the research adhered to the World Medical Association Declaration of Helsinki and/or relevant institutional, national, and international guidelines and regulations.
State that informed consent was obtained from all participants, specifying whether consent was written or oral.
For minors, obtain consent from a parent or legal guardian.
Inform participants of the purpose of publication, potential risks and benefits, and their right to refuse or withdraw consent at any time.
Clearly declare any restrictions on the availability or use of human data.
Authors must protect the privacy and confidentiality of participants.
Identifying information (e.g., name, initials, date of birth, contact details, medical record or hospital numbers, geographical location) must not be published unless scientifically essential and explicit written consent is obtained.
Images containing identifiable features (e.g., facial photographs) require patient review and written consent prior to publication.
If the participant is deceased, consent must be obtained from the next of kin or legal representative.
Consent forms must include all essential elements as in the journal’s sample form.
All submissions will be checked for adequate documentation of patient consent and removal/masking of identifiable information.
For studies involving regulated animals (all live vertebrates and higher invertebrates), authors must:
Identify the approving animal ethics committee in the Materials and Methods section, including the committee’s name and approval identifiers.
Provide proof of ethics approval or written confirmation if identifiers are not available.
For non-regulated animals, include a statement explaining why ethical approval was not required.
Follow the ARRIVE guidelines for reporting animal research.
Provide details on species, strain, sex, age, weight, housing, husbandry, and welfare measures, including steps taken to minimize pain and distress.
For research involving non-human primates, comply with the Weatherall Report recommendations.
To ensure reproducibility, authors must:
Specify all cell lines used, including their source/origin.
Provide information on authentication and mycoplasma testing.
For de novo human cell lines derived from tissue, obtain ethics committee approval and include committee name and approval identifiers in the Materials and Methods section.
Submit proof of ethics approval or written confirmation if identifiers are not available.
Confirm that informed consent for tissue donation was obtained from the donor or next of kin.